201 related articles for article (PubMed ID: 17046860)
1. Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L
Rheumatology (Oxford); 2006 Dec; 45(12):1497-504. PubMed ID: 17046860
[TBL] [Abstract][Full Text] [Related]
2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
3. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
[TBL] [Abstract][Full Text] [Related]
4. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
5. Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
Johnston O; Cassidy H; O'Connell S; O'Riordan A; Gallagher W; Maguire PB; Wynne K; Cagney G; Ryan MP; Conlon PJ; McMorrow T
Proteomics Clin Appl; 2011 Aug; 5(7-8):422-31. PubMed ID: 21751411
[TBL] [Abstract][Full Text] [Related]
6. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
7. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
8. [Urinary fibronectin as an indicator of kidney fibrosis in nephritis].
Kozlovskaia LV; Bobkova IN; Varshavskiĭ VA; Proskurneva EP; Miroshnichenko NG; Chebotareva NV; Mukhin NA
Ter Arkh; 1999; 71(6):34-8. PubMed ID: 10420453
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery in human SLE nephritis.
Rovin BH; Birmingham DJ; Nagaraja HN; Yu CY; Hebert LA
Bull NYU Hosp Jt Dis; 2007; 65(3):187-93. PubMed ID: 17922668
[TBL] [Abstract][Full Text] [Related]
10. Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.
Becker AM; Das S; Xia Z; Liu Z; Adam BL; Kountakis SE
Am J Rhinol; 2008; 22(2):139-43. PubMed ID: 18416969
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
12. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
13. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
[TBL] [Abstract][Full Text] [Related]
14. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
Dai Y; Hu C; Wang L; Huang Y; Zhang L; Xiao X; Tan Y
Scand J Rheumatol; 2010 May; 39(3):240-6. PubMed ID: 20166849
[TBL] [Abstract][Full Text] [Related]
15. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
16. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
18. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.
Das S; Maeso PA; Becker AM; Prosser JD; Adam BL; Kountakis SE
Laryngoscope; 2008 Dec; 118(12):2231-4. PubMed ID: 18978510
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis.
Mao Y; Yu J; Chen J; Yang H; He Q; Shou Z; Wu J; Zheng S
Transpl Immunol; 2008 Jan; 18(3):255-9. PubMed ID: 18047934
[TBL] [Abstract][Full Text] [Related]
20. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]